These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26436201)

  • 21. Epidemiological aspects of the genotype of hepatitis C virus.
    Xu B; Lu P; Zhu M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):148-50. PubMed ID: 11503047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients.
    Petruzziello A; Coppola N; Loquercio G; Marigliano S; Giordano M; Azzaro R; Diodato AM; Iervolino V; Di Costanzo G; Di Macchia CA; Di Meo T; Paradiso L; Ferro R; Giuliano P; Russo F; Pasquale G; Cacciapuoti C
    Intervirology; 2014; 57(6):311-8. PubMed ID: 25170801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.
    Heil J; Soufidi K; Stals F; Frantzen H; Robroek-Schaecken A; Bakker CM; van Nunen AB; Dukers-Muijrers NHTM; Hoebe CJPA
    Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):851-856. PubMed ID: 31688310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals.
    Nguyen LT; Gray E; Dean J; Carr M; Connell J; De Gascun C; Nguyen LA; O'Leary A; Bergin C; Hall W; Norris S
    Antivir Ther; 2015; 20(8):865-9. PubMed ID: 25920764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.
    McAdam-Marx C; McGarry LJ; Hane CA; Biskupiak J; Deniz B; Brixner DI
    J Manag Care Pharm; 2011 Sep; 17(7):531-46. PubMed ID: 21870894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in hepatitis C-related liver disease in a large clinic population.
    Ostapowicz G; Dallinger M; Bell SJ; Strasser SI; Watson KJ; Slavin J; Santamaria J; Desmond PV
    Intern Med J; 2001 Mar; 31(2):90-6. PubMed ID: 11480484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes.
    Ross RS; Viazov S; Renzing-Köhler K; Roggendorf M
    J Med Virol; 2000 Feb; 60(2):122-5. PubMed ID: 10596009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
    Hézode C; Fontaine H; Dorival C; Zoulim F; Larrey D; Canva V; De Ledinghen V; Poynard T; Samuel D; Bourliere M; Alric L; Raabe JJ; Zarski JP; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; Chazouilleres O; Abergel A; Guyader D; Metivier S; Tran A; Di Martino V; Causse X; Dao T; Lucidarme D; Portal I; Cacoub P; Gournay J; Grando-Lemaire V; Hillon P; Attali P; Fontanges T; Rosa I; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP;
    Gastroenterology; 2014 Jul; 147(1):132-142.e4. PubMed ID: 24704719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C.
    Grigorescu M;
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):45-50. PubMed ID: 19337633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCV non-1b genotypes in injecting drug users from Romania.
    Ruta S; Sultana C; Oprea C; Vagu C; Ceausu E; Cernescu C
    J Infect Dev Ctries; 2016 May; 10(5):523-7. PubMed ID: 27249529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark.
    Eriksen MB; Jørgensen LB; Krarup H; Laursen AL; Christensen PB; Møller A; Schlichting P; Kuiken C; Bukh J; Weis N;
    J Med Virol; 2010 Nov; 82(11):1869-77. PubMed ID: 20872713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy.
    De Conto F; Medici MC; Ferraglia F; Pinardi F; Fazzi A; Arcangeletti MC; Chezzi C; Calderaro A
    Arch Virol; 2016 Oct; 161(10):2727-37. PubMed ID: 27422399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
    Karatapanis S; Tsoplou P; Papastergiou V; Vasiageorgi A; Stampori M; Saitis I; Tsitsopoulos E; Lisgos P; Skorda L; Ketikoglou I; Goulis I
    J Med Virol; 2012 Feb; 84(2):223-8. PubMed ID: 22170541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease.
    Bokharaei-Salim F; Keyvani H; Monavari SH; Alavian SM; Madjd Z; Toosi MN; Mohammad Alizadeh AH
    J Med Virol; 2011 Jun; 83(6):989-95. PubMed ID: 21503911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.